Monitoring Patients on Treatment for MF

Opinion
Video

Aaron Gerds, MD, MS, explains that myelofibrosis patients on JAK inhibitors need regular monitoring of blood counts, liver enzymes, and cardiac events to check for reactivation.

Related Videos
Related Content